Qingbin Yao

832 total citations
13 papers, 668 citations indexed

About

Qingbin Yao is a scholar working on Cancer Research, Molecular Biology and Cell Biology. According to data from OpenAlex, Qingbin Yao has authored 13 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Qingbin Yao's work include Cancer-related molecular mechanisms research (6 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Qingbin Yao is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Hippo pathway signaling and YAP/TAZ (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Qingbin Yao collaborates with scholars based in China. Qingbin Yao's co-authors include Lina Zheng, Kun Zhang, Hong Wei, Xiaohui Han, Zhimei Hu, Zhemin Shi, Yawei Han, Hongmei Cui, Tao Han and Ting Chen and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qingbin Yao

13 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingbin Yao China 11 372 342 174 121 83 13 668
Jiangtong Peng China 15 525 1.4× 257 0.8× 108 0.6× 21 0.2× 86 1.0× 23 761
Michele Carrer United States 7 435 1.2× 208 0.6× 181 1.0× 35 0.3× 44 0.5× 12 636
Núria Tarrats United Kingdom 12 337 0.9× 83 0.2× 224 1.3× 158 1.3× 99 1.2× 13 763
Zhen‐Sheng Yue China 9 162 0.4× 67 0.2× 138 0.8× 99 0.8× 48 0.6× 14 367
John Stoops United States 11 247 0.7× 48 0.1× 161 0.9× 126 1.0× 93 1.1× 16 493
Baoyong Zhou China 12 238 0.6× 100 0.3× 92 0.5× 39 0.3× 73 0.9× 40 481
Junliang Pu China 11 243 0.7× 124 0.4× 91 0.5× 68 0.6× 92 1.1× 22 447
Rihua Zhang China 14 309 0.8× 78 0.2× 77 0.4× 25 0.2× 52 0.6× 24 501
Adel Hammoutène France 9 279 0.8× 86 0.3× 496 2.9× 211 1.7× 93 1.1× 14 796
Raul Lazaro United States 8 249 0.7× 54 0.2× 313 1.8× 110 0.9× 41 0.5× 8 570

Countries citing papers authored by Qingbin Yao

Since Specialization
Citations

This map shows the geographic impact of Qingbin Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbin Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbin Yao more than expected).

Fields of papers citing papers by Qingbin Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbin Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbin Yao. The network helps show where Qingbin Yao may publish in the future.

Co-authorship network of co-authors of Qingbin Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbin Yao. A scholar is included among the top collaborators of Qingbin Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbin Yao. Qingbin Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Han, Xiaohui, Yehua Li, Jiajun Wang, et al.. (2023). lncRNA Helf promotes hepatic inflammation and fibrosis by interacting with PTBP1 to facilitate PIK3R5 mRNA stabilization. Cellular & Molecular Biology Letters. 28(1). 77–77. 6 indexed citations
2.
Chen, Ting, Zhemin Shi, Lina Zheng, et al.. (2022). LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway. BMC Medicine. 20(1). 335–335. 35 indexed citations
3.
Liu, Qi, Xiaoxiao Du, Qingbin Yao, et al.. (2022). STARD5 as a potential clinical target of hepatocellular carcinoma. Medical Oncology. 39(10). 156–156. 5 indexed citations
4.
Han, Xiaohui, Qingbin Yao, Kun Zhang, et al.. (2019). 1α,25-dihydroxyvitamin D3 attenuates oxidative stress-induced damage in human trabecular meshwork cells by inhibiting TGFβ-SMAD3-VDR pathway. Biochemical and Biophysical Research Communications. 516(1). 75–81. 15 indexed citations
5.
Zhang, Kun, Mengxia Zhang, Qingbin Yao, et al.. (2019). The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition. Theranostics. 9(25). 7566–7582. 39 indexed citations
6.
Zhang, Kun, Yawei Han, Zhimei Hu, et al.. (2019). SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker. Theranostics. 9(12). 3622–3638. 60 indexed citations
7.
Shi, Zhemin, Kun Zhang, Jingzhao Wang, et al.. (2017). BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer’s disease mouse model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(9). 2398–2407. 25 indexed citations
8.
Zhang, Kun, Xiaohui Han, Zhen Zhang, et al.. (2017). The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. Nature Communications. 8(1). 144–144. 215 indexed citations
9.
Yao, Qingbin, et al.. (2017). Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling. Biochemical and Biophysical Research Communications. 493(4). 1396–1401. 14 indexed citations
10.
Shi, Zhemin, Ting Chen, Qingbin Yao, et al.. (2017). The circular RNA ciRS‐7 promotes APP and BACE1 degradation in an NF‐κB‐dependent manner. FEBS Journal. 284(7). 1096–1109. 132 indexed citations
11.
Zhang, Kun, Yanan Chang, Zhemin Shi, et al.. (2016). ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation. Scientific Reports. 6(1). 30029–30029. 50 indexed citations
12.
13.
Zhang, Kun, Zhimei Hu, Hai-Xia Qi, et al.. (2016). G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway. Oncotarget. 7(36). 58315–58330. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiangtong Peng Breakdown of academic impact, for papers by Michele Carrer Breakdown of academic impact, for papers by Núria Tarrats Breakdown of academic impact, for papers by Zhen‐Sheng Yue Breakdown of academic impact, for papers by John Stoops Breakdown of academic impact, for papers by Baoyong Zhou Breakdown of academic impact, for papers by Junliang Pu Breakdown of academic impact, for papers by Rihua Zhang Breakdown of academic impact, for papers by Adel Hammoutène Breakdown of academic impact, for papers by Raul Lazaro
Rankless by CCL
2026